WebApr 7, 2024 · On March 22, 2024, at the request of the U.S. Food and Drug Administration (“FDA”), Ascend Laboratories LLC. (“Ascend”) issued a voluntary nationwide recall of certain lots of Dabigatran Etexilate Capsules, a blood thinner medication, because of potential nitrosamine contamination.[i] Ascend is the most recent pharmaceutical … WebJan 5, 2024 · A new recall of extended-release metformin has been announced by the U.S. Food and Drug Administration (FDA) due to concerns about a potentially cancer-causing chemical — with some health experts asking if manufacturing processes need to be improved to avoid such recalls in the first place. The new recall, announced on …
Drug Recalls FDA - U.S. Food and Drug Administration
WebJan 8, 2024 · A new batch of metformin extended release tablets used to treat type 2 diabetes has been voluntarily recalled due to high levels of a carcinogen called N-Nitrosodimenthylamine (NDMA). Web282 rows · Jan 13, 2024 · Find out which specific metformin products are affected by the recall. FDA Updates and Press Announcements on NDMA in Metformin. Company. Medicine. NDC. Lot Number. Expiration. Amneal ... 11/22/2024 FDA alerts health ... 10/17/2016 Proposed rule to amend the list of drug … FDA published a recalled metformin list including details about metformin … mlock light
New Metformin Recall Follows Familiar Pattern - DSM
WebJan 3, 2024 · Viona Pharmaceuticals, Inc., is voluntarily recalling 33 lots of metformin hydrochloride extended-release tablets, USP 750 mg, due to presence of N-Nitrosodimethylamine, or NDMA, according to a... WebMar 23, 2024 · Pfizer has recalled three blood pressure medications over concerns they are tainted with a possible carcinogen. Its New York City headquarters is shown on March 1. Distributors and wholesalers ... WebMar 23, 2024 · March 23, 2024. Pfizer is recalling some shipments of its blood pressure drug Accuretic, as well as authorized generic versions of the medication, saying that a cancer … mlock mount flashlight